Beijing SL Pharmaceutical Co., Ltd. (002038)

Overview

Beijing SL Pharmaceutical Co., Ltd. is a prominent biopharmaceutical entity engaged in the development, production, and marketing of genetic engineering drugs and related pharmaceutical products. Its scope of operations extends beyond the domestic borders of the People’s Republic of China, reaching an international clientele. Originally established under the name Beijing BaiLuyuan Bio-Pharmaceutical Co., Ltd., the company underwent a rebranding in 1998 to its current name, marking a significant milestone in its corporate evolution. Founded in 1994, Beijing SL Pharmaceutical has its headquarters in Beijing, China, where it continues to develop pharmaceutical innovations aimed at addressing a wide range of medical challenges. Through its comprehensive portfolio, the company has established itself as a key player in the pharmaceutical industry, offering a broad spectrum of therapeutic solutions ranging from oncology to diabetic care and beyond.

Products and Services

Beijing SL Pharmaceutical Co., Ltd. boasts an extensive array of finished pharmaceutical formulations and active pharmaceutical ingredients (APIs) designed to cater to various therapeutic areas. Here’s a closer look at some of the key products and services offered by the company:

• Temozolomide, Arsentic Trioxide, lenalidomide capsules - Key offerings in the oncology segment, these drugs are employed in cancer treatment protocols.
• Docetaxel, Paclitaxel - Used primarily for cancer therapy, these compounds are part of the company’s robust anti-cancer drug lineup.
• Recombinant Human Granulocyte Colony-Stimulating Factor, Recombinant Human Interleukin - These biotechnological innovations play crucial roles in stimulating immune responses.
• Insulin Aspart, Liraglutide - Focused on diabetes management, these products exemplify the company’s commitment to addressing chronic conditions.
• Nimustine Hydrochloride, Asparaginase - Part of the company’s arsenal for treating various cancers, highlighting its depth in oncological care.
• Rivaroxaban, Enoxaparin Sodium - Representing the cardiovascular segment, these medications are used in the management of blood clots.
• Ginkgo Biloba Extract, Coenzyme Complex - Illustrative of Beijing SL Pharmaceutical's interest in both traditional and innovative therapeutic options.
• Valacylovir Hydrochloride, Tenofovir Disoproxil Fumarate - Addressing viral infections, these products are vital in the company’s infectious disease portfolio.
• Ornidazole, Levofloxacin Hydrochloride - Key antibiotics offered by the company, utilized in the treatment of bacterial infections.
• Active Pharmaceutical Ingredients (APIs) - The company also specializes in the production of high-quality APIs, serving as the cornerstone for pharmaceutical manufacturing.

This extensive product portfolio underscores Beijing SL Pharmaceutical Co., Ltd.'s comprehensive approach to healthcare, focusing on a diverse array of therapeutic areas and ensuring wide-ranging medical needs are met.